Literature DB >> 17630868

Medication use among children with autism spectrum disorders.

Donald P Oswald1, Neil A Sonenklar.   

Abstract

The study characterizes the use of psychoactive medications among children and youth with autism-spectrum disorders over the course of a calendar year. Eighty-three percent of the sample had at least one drug claim during the year. Prescribed drugs came from 125 different therapeutic classes. The seven most frequently prescribed classes of psychoactive drugs were antidepressants, stimulants, tranquilizers/antipsychotics, anticonvulsants, hypotensive agents, anxiolytic/sedative/hypnotics, and benzodiazepines. The data on other relevant diagnoses indicate that children and youth are frequently treated with medication under an autism-spectrum diagnosis, even though the target symptoms may be commonly associated with other mental disorders. Age data indicate that about 70% of children with autism-spectrum disorders age 8 yr and up receive some form of psychoactive medication in a given year.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630868     DOI: 10.1089/cap.2006.17303

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  60 in total

1.  Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.

Authors:  Thomas W Frazier; Paul T Shattuck; Sarah Carter Narendorf; Benjamin P Cooper; Mary Wagner; Edward L Spitznagel
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-13       Impact factor: 2.576

2.  Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Authors:  Lawrence Scahill; Christopher J McDougle; Michael G Aman; Cynthia Johnson; Benjamin Handen; Karen Bearss; James Dziura; Eric Butter; Naomi G Swiezy; L Eugene Arnold; Kimberly A Stigler; Denis D Sukhodolsky; Luc Lecavalier; Stacie L Pozdol; Roumen Nikolov; Jill A Hollway; Patricia Korzekwa; Allison Gavaletz; Arlene E Kohn; Kathleen Koenig; Stacie Grinnon; James A Mulick; Sunkyung Yu; Benedetto Vitiello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-12-23       Impact factor: 8.829

3.  Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias.

Authors:  Melisa Carrasco; Fred R Volkmar; Michael H Bloch
Journal:  Pediatrics       Date:  2012-04-23       Impact factor: 7.124

4.  Medical expenditures for children with an autism spectrum disorder in a privately insured population.

Authors:  Tom T Shimabukuro; Scott D Grosse; Catherine Rice
Journal:  J Autism Dev Disord       Date:  2007-08-10

5.  Treatment of comorbid anxiety and autism spectrum disorders.

Authors:  Joshua Nadeau; Michael L Sulkowski; Danielle Ung; Jeffrey J Wood; Adam B Lewin; Tanya K Murphy; Jill Ehrenreich May; Eric A Storch
Journal:  Neuropsychiatry (London)       Date:  2011-12

6.  Using a self-organizing map algorithm to detect age-related changes in functional connectivity during rest in autism spectrum disorders.

Authors:  Jillian Lee Wiggins; Scott J Peltier; Samantha Ashinoff; Shih-Jen Weng; Melisa Carrasco; Robert C Welsh; Catherine Lord; Christopher S Monk
Journal:  Brain Res       Date:  2010-11-01       Impact factor: 3.252

7.  Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

Authors:  Rebecca E Rosenberg; David S Mandell; Janet E Farmer; J Kiely Law; Alison R Marvin; Paul A Law
Journal:  J Autism Dev Disord       Date:  2010-03

8.  Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.

Authors:  Marco Lamberti; Rosamaria Siracusano; Domenico Italiano; Norma Alosi; Francesca Cucinotta; Gabriella Di Rosa; Eva Germanò; Edoardo Spina; Antonella Gagliano
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022

9.  Alterations of resting state functional connectivity in the default network in adolescents with autism spectrum disorders.

Authors:  Shih-Jen Weng; Jillian Lee Wiggins; Scott J Peltier; Melisa Carrasco; Susan Risi; Catherine Lord; Christopher S Monk
Journal:  Brain Res       Date:  2009-12-11       Impact factor: 3.252

10.  Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey.

Authors:  Lynn K Koegel; Anna M Krasno; Howard Taras; Robert L Koegel; William Frea
Journal:  School Ment Health       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.